Terms: = Brain cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Treatment
2764 results:
1. MASCC 2023 Patient-Centered Antiemetic Guidelines and Education Statements: an evidence-based and consensus resource for patients.
Affronti ML; Lee J; Molassiotis A; Johnson L; Tinianov S; Clark-Snow R; Scotte F
Support Care Cancer; 2024 May; 32(6):335. PubMed ID: 38727834
[TBL] [Abstract] [Full Text] [Related]
2. Gedunin modulates cellular growth and apoptosis in glioblastoma cell lines.
Stouffer M; Wandling E; Dickson L; Lin S; Duan H; Powe E; Jean-Louis D; Tiwari AK; Amos S
Cancer Rep (Hoboken); 2024 May; 7(5):e2051. PubMed ID: 38702989
[TBL] [Abstract] [Full Text] [Related]
3. Prognosis versus Actual Outcomes in Stereotactic Radiosurgery of brain Metastases: Reliability of Common Prognostic Parameters and Indices.
Mangesius J; Seppi T; Arnold CR; Mangesius S; Kerschbaumer J; Demetz M; Minasch D; Vorbach SM; Sarcletti M; Lukas P; Nevinny-Stickel M; Ganswindt U
Curr Oncol; 2024 Mar; 31(4):1739-1751. PubMed ID: 38668035
[TBL] [Abstract] [Full Text] [Related]
4. Simultaneous boost radiotherapy versus conventional dose radiotherapy for patients with newly diagnosed glioblastoma: a multi-institutional analysis.
Takano S; Tomita N; Kuno M; Niwa M; Torii A; Takaoka T; Kita N; Okazaki D; Yamamoto S; Kawai T; Sugie C; Ogawa Y; Matsumoto K; Uchiyama K; Otsuka S; Matsui T; Miyakawa A; Mizuno T; Iida M; Tanikawa M; Mase M; Hiwatashi A
Sci Rep; 2024 Apr; 14(1):9283. PubMed ID: 38654028
[TBL] [Abstract] [Full Text] [Related]
5. Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis.
Gecici NN; Gurses ME; Kaye B; Jimenez NLF; Berke C; Gökalp E; Lu VM; Ivan ME; Komotar RJ; Shah AH
J Neurooncol; 2024 May; 168(1):1-11. PubMed ID: 38619777
[TBL] [Abstract] [Full Text] [Related]
6. B7-H3 Expression in Breast cancer and brain Metastasis.
Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
[TBL] [Abstract] [Full Text] [Related]
7. Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E.
Chen MF; Song Z; Yu HA; Sequist LV; Lovly CM; Mitchell EP; Moscow JA; Gray RJ; Wang V; McShane LM; Rubinstein LV; Patton DR; Williams PM; Hamilton SR; Umemura Y; Tricoli JV; Conley BA; Arteaga CL; Harris LN; O'Dwyer PJ; Chen AP; Flaherty KT
JCO Precis Oncol; 2024 Apr; 8():e2300454. PubMed ID: 38591867
[TBL] [Abstract] [Full Text] [Related]
8. Re-irradiation for recurrent intracranial meningiomas: Analysis of clinical outcomes and prognostic factors.
Desideri I; Morelli I; Banini M; Greto D; Visani L; Nozzoli F; Caini S; Della Puppa A; Livi L; Perini Z; Zivelonghi E; Bulgarelli G; Pinzi V; Navarria P; Clerici E; Scorsetti M; Ascolese AM; Osti MF; Anselmo P; Amelio D; Minniti G; Scartoni D
Radiother Oncol; 2024 Jun; 195():110271. PubMed ID: 38588920
[TBL] [Abstract] [Full Text] [Related]
9. Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer.
Divan HA; Bittoni MA; Krishna A; Carbone DP
BMC Cancer; 2024 Apr; 24(1):424. PubMed ID: 38580900
[TBL] [Abstract] [Full Text] [Related]
10. treatment of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM).
Benetti-Pinto CL; Prestes Nácul A; Rosa-E-Silva ACJS; Maciel GAR; Dos Santos Nunes Nogueira V; Condé Lamparelli Elias P; Martins M; Kasuki L; Mendes Garmes H; Glezer A
Arch Endocrinol Metab; 2024 Apr; 68():e230504. PubMed ID: 38578473
[TBL] [Abstract] [Full Text] [Related]
11. Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung cancer: A Meta-Analysis.
Chi C; Wang C; Dong L; Li X; Xu L
J Coll Physicians Surg Pak; 2024 Apr; 34(4):461-467. PubMed ID: 38576291
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of ASL and DSC perfusion methods in the evaluation of response to treatment in patients with a history of treatment for malignant brain tumor.
Bayraktar ES; Duygulu G; Çetinoğlu YK; Gelal MF; Apaydın M; Ellidokuz H
BMC Med Imaging; 2024 Mar; 24(1):70. PubMed ID: 38519901
[TBL] [Abstract] [Full Text] [Related]
13. Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging study.
Pruis IJ; van Doormaal PJ; Balvers RK; van den Bent MJ; Harteveld AA; de Jong LC; Konijnenberg MW; Segbers M; Valkema R; Verburg FA; Smits M; Veldhuijzen van Zanten SEM
EBioMedicine; 2024 Apr; 102():105068. PubMed ID: 38518652
[TBL] [Abstract] [Full Text] [Related]
14. Metabolic impairments associated with type 2 diabetes mellitus and the potential effects of exercise therapy: An exploratory randomized trial based on untargeted metabolomics.
Zhang F; Chen X; Yang M; Shen X; Wang Y; Zhong D; Zeng F; Jin R
PLoS One; 2024; 19(3):e0300593. PubMed ID: 38517904
[TBL] [Abstract] [Full Text] [Related]
15. Research on multi-model imaging machine learning for distinguishing early hepatocellular carcinoma.
Ma Y; Gong Y; Qiu Q; Ma C; Yu S
BMC Cancer; 2024 Mar; 24(1):363. PubMed ID: 38515051
[TBL] [Abstract] [Full Text] [Related]
16. Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.
Van Genechten T; De Laere M; Van den Bossche J; Stein B; De Rycke K; Deschepper C; Hazes K; Peeters R; Couttenye MM; Van De Walle K; Roelant E; Maes S; Vanden Bossche S; Dekeyzer S; Huizing M; Caluwaert K; Nijs G; Cools N; Verlooy J; Norga K; Verhulst S; Anguille S; Berneman Z; Lion E
BMJ Open; 2024 Mar; 14(3):e077613. PubMed ID: 38503417
[TBL] [Abstract] [Full Text] [Related]
17. The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database.
Zhu P; Pichardo-Rojas PS; Dono A; Tandon N; Hadjipanayis CG; Berger MS; Esquenazi Y
J Neurooncol; 2024 May; 168(1):77-89. PubMed ID: 38492191
[TBL] [Abstract] [Full Text] [Related]
18. Zeolitic imidazolate framework-90 loaded with methylprednisolone sodium succinate effectively reduces hypertrophic scar
Xu X; Liu J; Xiao Z; Li S; Zhang Y; Song P; Lin K; Zhang L; Zheng H; Zhou Y; Chen X
Nanoscale; 2024 Mar; 16(13):6708-6719. PubMed ID: 38488127
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of Volumetric and 2D Measurements and Longitudinal Trajectories in the Response Assessment of
Ramakrishnan D; Brüningk SC; von Reppert M; Memon F; Maleki N; Aneja S; Kazerooni AF; Nabavizadeh A; Lin M; Bousabarah K; Molinaro A; Nicolaides T; Prados M; Mueller S; Aboian MS
AJNR Am J Neuroradiol; 2024 Apr; 45(4):475-482. PubMed ID: 38453411
[TBL] [Abstract] [Full Text] [Related]
20. Gamma entrainment using audiovisual stimuli alleviates chemobrain pathology and cognitive impairment induced by chemotherapy in mice.
Kim T; James BT; Kahn MC; Blanco-Duque C; Abdurrob F; Islam MR; Lavoie NS; Kellis M; Tsai LH
Sci Transl Med; 2024 Mar; 16(737):eadf4601. PubMed ID: 38446899
[TBL] [Abstract] [Full Text] [Related]
[Next]
